Moreover, ADRB2 signaling regulates the immunosuppressive activity of MDSCs via STAT3‐mediated modulation of immunosuppressive molecules, such as arginase‐1 and PD‐L1, suggesting a potential role for sympathetic nerves in modulating the immune microenvironment in breast cancer [168]. This evidence concerns the gene ADRB2 and breast carcinoma.